These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20608354)

  • 1. [Effects of testosterone substitution on metabolic syndrome-related factors in hypogonadal males: a meta-analysis].
    Wan ZH; Wen YB; Ding QF; Xu TY
    Zhonghua Nan Ke Xue; 2010 Jun; 16(6):510-5. PubMed ID: 20608354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Testosterone replacement therapy improves metabolic indexes of the patients with hypogonadism: A meta-analysis].
    Wang W; Wu J; Fan YF; Yang ZP; Zhu W; Yang GT; He JB
    Zhonghua Nan Ke Xue; 2022 Oct; 28(10):926-934. PubMed ID: 37838960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study.
    Aversa A; Bruzziches R; Francomano D; Rosano G; Isidori AM; Lenzi A; Spera G
    J Sex Med; 2010 Oct; 7(10):3495-503. PubMed ID: 20646185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.
    Cai X; Tian Y; Wu T; Cao CX; Li H; Wang KJ
    Asian J Androl; 2014; 16(1):146-52. PubMed ID: 24369149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism.
    Sonmez A; Haymana C; Bolu E; Aydogdu A; Tapan S; Serdar M; Altun B; Barcin C; Taslipinar A; Meric C; Uckaya G; Kutlu M
    Eur J Endocrinol; 2011 May; 164(5):759-64. PubMed ID: 21325471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of testosterone supplement treatment in hypogonadal adult males with T2DM: a meta-analysis and systematic review.
    Zhang J; Yang B; Xiao W; Li X; Li H
    World J Urol; 2018 Aug; 36(8):1315-1326. PubMed ID: 29511802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone and metabolic syndrome: a meta-analysis study.
    Corona G; Monami M; Rastrelli G; Aversa A; Tishova Y; Saad F; Lenzi A; Forti G; Mannucci E; Maggi M
    J Sex Med; 2011 Jan; 8(1):272-83. PubMed ID: 20807333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of testosterone replacement therapy for treating metabolic disturbances in late-onset hypogonadism: a systematic review and meta-analysis.
    Kim SH; Park JJ; Kim KH; Yang HJ; Kim DS; Lee CH; Jeon YS; Shim SR; Kim JH
    Int Urol Nephrol; 2021 Sep; 53(9):1733-1746. PubMed ID: 34089171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging link between hypogonadism and metabolic syndrome.
    Guay AT
    J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone undecanoate improves lipid profile in patients with type 1 diabetes and hypogonadotrophic hypogonadism.
    Chillarón JJ; Fernández-Miró M; Albareda M; Fontserè S; Colom C; Vila L; Pedro-Botet J; Flores Le-Roux JA
    Endocr J; 2016 Sep; 63(9):849-855. PubMed ID: 27452372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of testosterone therapy in adult males with hypogonadism and T2DM: A meta-analysis and systematic review.
    Kumar S; Khatri M; Memon RA; Velastegui JL; Podaneva KZ; Gutierrez DB; Nadeem B; Anumolu AR; Azhar M; Zain A
    Diabetes Metab Syndr; 2022 Aug; 16(8):102588. PubMed ID: 35952509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study.
    Corona G; Giagulli VA; Maseroli E; Vignozzi L; Aversa A; Zitzmann M; Saad F; Mannucci E; Maggi M
    Eur J Endocrinol; 2016 Mar; 174(3):R99-116. PubMed ID: 26537862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome.
    Filippi S; Vignozzi L; Morelli A; Chavalmane AK; Sarchielli E; Fibbi B; Saad F; Sandner P; Ruggiano P; Vannelli GB; Mannucci E; Maggi M
    J Sex Med; 2009 Dec; 6(12):3274-88. PubMed ID: 19732305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of testosterone supplementation therapy on lipid metabolism in hypogonadal men with T2DM: a meta-analysis of randomized controlled trials.
    Zhang KS; Zhao MJ; An Q; Jia YF; Fu LL; Xu JF; Gu YQ
    Andrology; 2018 Jan; 6(1):37-46. PubMed ID: 28950433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypogonadism and metabolic syndrome: implications for testosterone therapy.
    Makhsida N; Shah J; Yan G; Fisch H; Shabsigh R
    J Urol; 2005 Sep; 174(3):827-34. PubMed ID: 16093964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone replacement therapy in obese males.
    Drewa T; Olszewska-Słonina D; Chlosta P
    Acta Pol Pharm; 2011; 68(5):623-7. PubMed ID: 21928705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes.
    Kapoor D; Channer KS; Jones TH
    Diab Vasc Dis Res; 2008 Jun; 5(2):135-7. PubMed ID: 18537102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study.
    Kalinchenko SY; Tishova YA; Mskhalaya GJ; Gooren LJ; Giltay EJ; Saad F
    Clin Endocrinol (Oxf); 2010 Nov; 73(5):602-12. PubMed ID: 20718771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism.
    Bojesen A; Kristensen K; Birkebaek NH; Fedder J; Mosekilde L; Bennett P; Laurberg P; Frystyk J; Flyvbjerg A; Christiansen JS; Gravholt CH
    Diabetes Care; 2006 Jul; 29(7):1591-8. PubMed ID: 16801584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of continuous long-term testosterone therapy (TTh) on anthropometric, endocrine and metabolic parameters for up to 10 years in 115 hypogonadal elderly men: real-life experience from an observational registry study.
    Yassin AA; Nettleship J; Almehmadi Y; Salman M; Saad F
    Andrologia; 2016 Sep; 48(7):793-9. PubMed ID: 26762680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.